iBrands Corporation Announces Clinical Trial For Immune Booster Product
June 17, 2020 09:00 ET
|
iBrands Corporation
LAS VEGAS, June 17, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces clinical trial for Quadramune™, the Company’s...
iBrands Corporation Adds Immune Booster To Nutraceutical Product Line
April 27, 2020 09:10 ET
|
iBrands Corporation
LAS VEGAS, April 27, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces that it has, through its wholly owned subsidiary...